Inventor · disambiguated record
Luca Gobbi
Also filed as: GOBBI LUCA · GOBBI LUCA CLAUDIO
54 granted patents·38 pending applications·329 citations·filing 2002–2025
98Inventor score
Top patents by PatentIndex Score
92 records- 0197US6727261B2Pyrido[2,1-A]Isoquinoline derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Apr 27, 2004·184 cites·17 claims
- 0294US11420961B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Aug 23, 2022·6 cites·19 claims
- 0392US11802133B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Granted Oct 31, 2023·2 cites·10 claims
- 0490US11814375B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Nov 14, 2023·2 cites·17 claims
- 0589US9957266B2Imidazo[1,2-a]pyridin-7-amineHOFFMANN LA ROCHE·Filed 2016·Granted May 1, 2018·4 cites·11 claims
- 0689US9522886B2Pyridine derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Dec 20, 2016·7 cites·18 claims
- 0789US6897222B2Pyrido[2,1-a]isoquinoline derivativesHOFFMANN LA ROCHE·Filed 2004·Granted May 24, 2005·31 cites·16 claims
- 0887US8178538B2PyridazinonesALBERATI DANIELA·Filed 2009·Granted May 15, 2012·16 cites·50 claims
- 0986US11739095B2Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulatorsHOFFMANN LA ROCHE·Filed 2021·Granted Aug 29, 2023·2 cites·2 claims
- 1085US8349824B2Triazolopyridine compoundsHOFFMANN LA ROCHE·Filed 2011·Granted Jan 8, 2013·9 cites·26 claims
- 1185US8039490B2Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptorsHOFFMANN LA ROCHE·Filed 2007·Granted Oct 18, 2011·7 cites·29 claims
- 1284US7858630B2D3 and 5-HT2A receptor modulatorsHOFFMANN LA ROCHE·Filed 2009·Granted Dec 28, 2010·7 cites·36 claims
- 1383US7795437B2Ether derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 14, 2010·6 cites·17 claims
- 1482US10004817B2Diazacarbazole derivatives as tau-PET-ligandsHOFFMANN LA ROCHE·Filed 2016·Granted Jun 26, 2018·3 cites·6 claims
- 1582US7825123B2Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptorsHOFFMANN LA ROCHE·Filed 2009·Granted Nov 2, 2010·5 cites·21 claims
- 1681US12281124B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2023·Granted Apr 22, 2025·0 cites·20 claims
- 1779US11058781B2Diazacarbazole derivatives as tau-PET-ligandsHOFFMANN LA ROCHE·Filed 2018·Granted Jul 13, 2021·1 cites·1 claims
- 1879US10138234B22-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Nov 27, 2018·3 cites·7 claims
- 1979US7939535B2Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptorsHOFFMANN LA ROCHE·Filed 2009·Granted May 10, 2011·3 cites·59 claims
- 2076US8415350B2Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptorsGOBBI LUCA·Filed 2011·Granted Apr 9, 2013·3 cites·5 claims
- 2176US7129238B2Mandelic acid derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Oct 31, 2006·10 cites·64 claims
- 2276US2025388586A1New benzodiazepine derivatives as gaba a gamma1 pamHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2375US7829563B2Aminoamides as orexin antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Nov 9, 2010·2 cites·28 claims
- 2475US7781441B2(3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amineHOFFMANN LA ROCHE·Filed 2006·Granted Aug 24, 2010·2 cites·24 claims
- 2575US7501541B2Malonamides as orexin antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Mar 10, 2009·2 cites·23 claims
- 2674US12365687B2Benzodiazepine derivatives as GABA A gamma 1 PAMHOFFMANN LA ROCHE·Filed 2022·Granted Jul 22, 2025·0 cites·2 claims
- 2774US8097637B2Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptorsGOBBI LUCA·Filed 2008·Granted Jan 17, 2012·2 cites·15 claims
- 2873US12344614B2Benzodiazepine derivatives as GABA a GAMMA1 PAMHOFFMANN LA ROCHE·Filed 2022·Granted Jul 1, 2025·0 cites·8 claims
- 2972US8829029B2Dual modulators of 5HT2A and D3 receptorsHOFFMANN LA ROCHE·Filed 2013·Granted Sep 9, 2014·1 cites·18 claims
- 3072US2024270744A1New pyrido diazepine derivatives as gaba a gamma1 pamHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3171US2024383872A1Novel pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3270US8410117B2Imidazopyrimidine derivativesALVAREZ SANCHEZ RUBEN·Filed 2011·Granted Apr 2, 2013·4 cites·26 claims
- 3367US10975073B2Imaging methods using 2-hetaryl imidazol[1,2-a]pyridine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Apr 13, 2021·0 cites·4 claims
- 3467US2024002393A1SUBSTITUTED BENZO[f][l ,2,4JTRIAZOL0[4,3-a][l ,4JDIAZEPINES AS GABA A GAMMA! POSITIVE ALLOSTERIC MODULATORSHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3566US8470828B2Anellated pyridine compoundsGOBBI LUCA·Filed 2011·Granted Jun 25, 2013·1 cites·33 claims
- 3666US2023117324A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3765US12071420B2Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2HOFFMANN LA ROCHE·Filed 2020·Granted Aug 27, 2024·0 cites·18 claims
- 3865US7056932B2Heterocyclyl substituted 1-alkoxy acetic acid amidesHOFFMANN LA ROCHE·Filed 2004·Granted Jun 6, 2006·2 cites·21 claims
- 3965US2023109111A1New pyrido diazepine derivatives as gaba a gamma1 pamHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 4065US2020308190A1Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4165US2024287082A1New benzodiazepine derivatives as gaba a gamma1 pamHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4264US11999710B2Radiolabeled cannabinoid receptor 2 ligandHOFFMANN LA ROCHE·Filed 2020·Granted Jun 4, 2024·0 cites·23 claims
- 4364US11117903B2Pyridine derivativesHOFFMANN LA ROCHE·Filed 2019·Granted Sep 14, 2021·0 cites·6 claims
- 4464US2024190889A1New cyclopenta-thieno-diazepine derivatives as gaba a gamma1 positive allosteric modulatorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4564US2024294543A1Cyclohepta-thieno-diazepine derivatives as gaba a gamma1 pamHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4663US2022106328A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4763US2009029977A1Dual modulators of 5ht2a and d3 receptorsGOBBI LUCA·Filed 2008·Application pending·0 cites
- 4863US2024308974A1Radiolabeled cannabinoid receptor 2 ligandHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4963US2024270725A1Magl inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 5062US12065399B2Arylsulfonamide derivativesHOFFMANN LA ROCHE·Filed 2022·Granted Aug 20, 2024·0 cites·17 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Luca Gobbi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →